According to a new report, global costs on cancer drugs spending has doubled over the past five years. The IQVIA Institute for Human Data Science (previously known as IMS Health and Quintiles) states that the average cost of a new cancer drug released in 2017 was $150,000 and unfortunately, these prices are expected to double again by 2022.
According to new report by the Congressional Budget Office, the price of Obamacare plans will rise by a staggering 15% next year. There’s also a projected 35 million uninsured people under 65 by 2027. Adding to the ongoing debate over the fate of ObamaCare, the double-digit premium increment would likely to happen during President Donald Trump’s third year in office.
According to a new poll by the American College of Emergency Physicians (ACEP), 9 out of 10 ER doctors say their hospitals aren’t fully prepared for mass tragedies or major disasters. This shocking revelation comes as the U.S. Congress considers major disaster preparedness legislation. The ACEP surveyed 1,328 emergency room doctors between April 25 and May 6 and 93 of the respondents stated that their ER would be unable to handle a surge of patients resulting from either a natural or human-caused disaster.
According to a new alarming study, the misuse of ADHD medication is increasing in the United States. Based on information published in the journal Pediatrics, there were 156,365 calls to poison control centers for people under 20 who were inappropriately exposed to ADHD medication from 2000 to 2014. Between 2000 and 2011, the number of calls increase then there was a slight decline between 2011 and 2014. Gary Smith, the senior author of the study stated that the call volume increase by 60% over the period.
The US Food and Drug Administration has given approval for the first drug specially designed to prevent debilitating chronic migraines. The drug is called Aimovig (AIM’-oh-vig) is considered to be the first in a completely new class of long-acting drugs for preventing migraines. It comes in the form of a monthly shot instead of a typical tablet or pill. Aside from Aimovig, there are also three other shots are expected to win approval by 2019. Amgen Inc. of Thousand Oaks, California and Swiss drug giant Novartis AG developed Aimovig. The drug is injected once a month just under the skin using a pen like device. Without insurance, it will cost a staggering $6,900 per year.
A recent study has found that the number of American teenagers hospitalized for suicide ideation or suicide attempts nearly doubled between 2008 and 2015 with the highest increase seen in adolescent girls. The study focused on children ages 5-17 years, and followed 115,856 cases at emergency departments at 31 children’s hospitals. More than half of the cases occurred in teens ages 15-17, with children ages 12-14 accounting for 37%, and 12.8% of cases involving kids ages 5-11.
A lawsuit has been filed on Monday by pro-choice advocates in an attempt to stop Iowa’s new law that bans abortions after 6 weeks. The Planned Parenthood Federation of America, Emma Goldman Clinic of Iowa City and the American Civil Liberties Union of Iowa have stated that this would be the most restrictive abortion ban in the US which violates women’s rights to get an abortion. The law is supposed to go into effect July 1. Republican Governor Kim Reynolds signed the bill into law earlier this month.
US First Lady Melania Trump has been admitted to hospital and has undergone surgery to treat a benign kidney condition. A statement was released by the White House on Monday afternoon, stating: “This morning, First Lady Melania Trump underwent an embolization procedure to treat a benign kidney condition. The procedure was successful and there were no complications.”
According to new data, major depression is skyrocketing among Americans across all age groups but teenagers and young adults are the ones being hit the hardest with depression. The rates of depression vary among the states with Hawaii having the lowest rate at 2.1% while Rhode Island has the highest rate at 6.4%